Advanced
Biostatistics
Innovative Clinical
Trial Design
Sample Size Estimation
Expert Statistical
Programming
Adaptive Trials
Methodologies
Comprehensive
Survival Analysis
Specialized
Oncology Expertise
Pharmacokinetic and
Bioequivalence Studies
Therapeutic
Area Proficiency
Extensive Clinical
Trials Experience
1. Advanced Biostatistics
Stay Ahead, Stay Smart
At PHARMA-STATS, we’re all about staying ahead of the curve in biostatistics. We don’t just stick to the tried-and-true methods; we’re constantly learning, adapting, and embracing the latest trends like Data Visualization and Automation. Our mission? To provide innovative, efficient, and regulatory-compliant biostatistical solutions that keep your clinical trials running smoothly.
Always Learning, Always Evolving
Our team is committed to professional growth. Whether it’s through global conferences, academic collaborations, or hands-on training, we stay up-to-date with cutting-edge trends like machine learning in clinical trials, real-world evidence analysis, and the use of AI-based predictive models. This ensures our clients benefit from the latest and most effective biostatistical techniques.
Why PHARMA-STATS?
- Latest Methodologies: We don’t wait for change, we lead it. We implement the most current advancements to give your trials the edge.
- Innovative Trial Designs: From adaptive trials to Phase II/III seamless designs to RWE, we ensure your clinical trials are efficient and flexible.
- AI and Machine Learning: We integrate these tools to boost accuracy and predictability in your trial outcomes.
- Collaboration: By staying active in the scientific community, we ensure your trial is benefiting from the latest research and best practices.
We’re not just here to analyze data; we’re here to innovate the future of clinical trials, making sure your projects are not just compliant, but cutting-edge.
2. Innovative Clinical Trial Design
Shaping the Future of Trials
We’re all about pushing boundaries at PHARMA-STATS. That’s why our trial designs are built with innovation in mind, whether it’s through adaptive designs or cutting-edge methods. We make clinical trials more efficient and effective, especially in complex areas like oncology and rare diseases, where flexibility and speed are key.
Collaboration is Key
We believe that the best ideas come from collaboration. That’s why we work closely with industry experts, academic researchers, and regulatory bodies to evolve and refine our methodologies. Whether it’s participating in workshops, symposiums, or industry events, we’re always learning and improving to make sure you get the most forward-thinking solutions.
Always Learning, Always Leading
We don't just offer services—we lead the way in biostatistical innovation. Our continuous professional development and involvement in the latest research trends make us the perfect partner to deliver scientifically robust, innovative solutions that meet regulatory standards.
Why PHARMA-STATS?
- Up-to-date Tech: We integrate the newest advancements in biostatistics, ensuring your trials stay on the cutting edge.
- Flexible Trial Designs: From adaptive trials to seamless Phase II/III designs to RWE, we provide trial solutions that grow with your study.
- AI & Machine Learning: By embracing AI and machine learning, we supercharge your trial's accuracy and outcomes.
- Collaborative Spirit: We don’t just follow trends—we help shape them, working with the brightest minds in biostatistics.
At PHARMA-STATS, we’re always pushing forward, offering clinical trials that are not only compliant but innovative, efficient, and future-ready. Let’s take your trial to the next level.
3. Sample Size Estimation
At PHARMA-STATS, we know sample size isn’t just about filling seats; it’s about striking the perfect balance between statistical power and practical feasibility. The goal? Getting a sample size that can detect real treatment effects without wasting time, resources, or putting patients at unnecessary risk.
Why Precision Matters
A well-calculated sample size answers the big questions:
- Can we detect meaningful differences between groups?
- Are the time, resources, and participant numbers worth it?
Undershooting can lead to missed findings (false negatives), while overshooting wastes time and money. At PHARMA-STATS, we make sure your trial size is just right to deliver reliable, actionable results, all while keeping patient care at the heart of the process.
Key Elements in Sample Size Calculation:
- Choosing the Right Endpoint:
- Binary Endpoints: Did the event happen, yes or no? We use proportion comparisons to calculate sample sizes for binary outcomes, like symptom relief or disease progression.
- Continuous Endpoints: These look at variables like blood pressure levels. We use a two-sample t-test to calculate the ideal sample size, factoring in the effect size, variability, and significance level.
- Time-to-Event Endpoints: Think survival or relapse. These are analyzed using methods like Kaplan-Meier or Cox proportional hazards models, with sample size based on expected event rates.
- Statistical Power: Power determines the likelihood of detecting a true effect, typically set between 80-90%. We make sure your trial is powered to find meaningful differences, no matter the endpoint.
- Effect Size and Variability: The more variability in your data, the bigger the sample size you need to detect meaningful differences. We ensure we get this balance right every time.
Why Sample Size is Key
It's more than just a regulatory checkbox. The right sample size ensures ethical study conduct—only enrolling the participants you really need, ensuring you get meaningful data that leads to real-world, actionable insights.
How PHARMA-STATS Optimizes Your Sample Size:
Our sample size calculations aren’t guesswork. We take a holistic approach, balancing statistical theory with patient-centered ethics. Using advanced software and models, we make sure your trial is powered to deliver clinically meaningful results while staying aligned with global regulatory guidelines.
At PHARMA-STATS, we’re here to make sure your trial is scientifically solid, cost-effective, and always focused on patient care.
4. Expert Statistical Programming
At PHARMA-STATS, we’ve mastered the art of data crunching through cutting-edge programming skills, designed for today’s fast-paced, high-stakes clinical trials. With expertise in R, Python, and SAS, we’re all about delivering fast, precise, and compliant solutions. Our team knows how to make clinical trial data work for you, optimizing both time and resources while ensuring top-notch regulatory compliance.
Here’s Why We’re Next-Level:
- R Programming: Think of R as the Swiss Army knife of statistical programming. From high-impact data visualizations to complex models, we use R to bring clarity and depth to your trial data. With thousands of CRAN packages, we make sure your data is handled with transparency, traceability, and accuracy, ensuring that every analysis we do meets the highest standards of reproducibility.
- Python: Fast, efficient, and adaptable, Python allows us to handle massive datasets and execute cutting-edge machine learning models. Whether automating workflows or running predictive analytics, Python gives us the speed and agility needed to accelerate your clinical trials.
- SAS*: Our team knows how to leverage its power to handle complex datasets and generate submission-ready reports with zero compromise on quality. *Applicable in cases of Full-Time Employee (FTE) models.
What’s in it for You?
- Speed and Scale: Whether your trial involves hundreds or thousands of patients, our programming solutions can scale without losing precision.
- Compliance First: Our team delivers statistical analyses fully aligned with the rigorous standards of agencies, ensuring seamless regulatory submissions.
- Tailored to Your Needs: Every trial is different, and we design our workflows to match your exact needs—whether it’s automating data cleaning or crunching numbers for interim analyses.
Why It Matters:
In today’s world, data is king. Our R-based solutions have been behind successful regulatory submissions, meaning we’ve helped companies navigate the complex maze of regulatory requirements with confidence. We’re not just coding for the sake of it; we’re coding to win your trials. With tools like Shiny apps and advanced visualizations, we help you make sense of the numbers, empowering your team to make informed, data-driven decisions faster than ever.
Ready to Roll?
Let’s transform your clinical trial data with precision, speed, and innovation. When you choose PHARMA-STATS, you’re choosing a team that’s not only ahead of the curve but actively shaping the future of statistical programming in clinical research.
5. Adaptive Trials Design
At PHARMA-STATS, we leverage adaptive trial designs to bring flexibility, efficiency, and precision to clinical trials. Adaptive designs allow for real-time adjustments based on the interim results of an ongoing study, offering a dynamic approach compared to traditional fixed designs. These modifications can involve changes to sample size, dose regimens, or patient selection criteria, while maintaining the trial’s statistical integrity.
Why Adaptive Designs?
Adaptive trials accelerate the drug development process by enabling early decisions, reducing patient exposure to ineffective treatments, and increasing overall trial efficiency. These designs shine in areas like oncology, rare diseases, and precision medicine, where unpredictability in outcomes can make recruitment tough and timing crucial.
PHARMA-STATS' Role in Adaptive Trials
Our biostatisticians provide end-to-end support for adaptive designs, from protocol development to interim analyses and regulatory submissions. We employ advanced statistical modelling tools, simulation-based planning, and regulatory-compliant strategies to ensure that every modification is scientifically sound and aligns with the trial’s objectives.
Why Adaptive Designs Work:
- Flexibility: Make informed adjustments without compromising trial quality, allowing for real-time decisions that speed up success.
- Ethics First: Adaptive designs mean fewer patients are exposed to ineffective treatments, and those on promising therapies get access faster.
- Cost & Time Efficiency: Early trial terminations for futility or success cut down on both time and money, fast-tracking the path to market.
At PHARMA-STATS, we ensure that every adaptive design we implement meets regulatory standards, leveraging the latest methodologies to optimize trial outcomes and regulatory approvals. With expertise in handling complex data and statistical models, we offer pharmaceutical companies’ innovative solutions for faster, more efficient drug development processes.
By choosing adaptive designs with PHARMA-STATS, your trials benefit from dynamic strategies that ensure ethical, efficient, and patient-centred outcomes.
6. Comprehensive Survival Analysis
Time-to-Event, Done Right
At PHARMA-STATS, we bring expertise in survival analysis to help you track patient outcomes over time, making it a crucial tool for evaluating the long-term impact of treatments, especially in fields like oncology and chronic disease research.Â
Whether it's understanding how long patients survive, relapse, or progress, we’ve got you covered with advanced, tailored statistical methods that keep your data precise, reproducible, and always aligned with regulatory standards.
Why Survival Analysis?
- Longitudinal Insights: Know how your treatment impacts patients over time—be it survival, progression-free survival, or relapse rates.
- Handling Censored Data: We deal with incomplete data head-on, making sure even partial data contributes to the overall analysis.
Adaptive Insights: We help your trial adjust as results come in, keeping you on top of every new development.
Our Expertise:
- Kaplan-Meier Estimates: Perfect for visualizing survival functions and comparing groups over time.
- Cox Proportional Hazards Models: Dive deep into understanding the risk factors and their impact on patient outcomes, while adjusting for covariates.
- Regulatory Compliance: Our analyses are fully aligned with regulatory agencies, and other global regulatory standards, ensuring smooth submissions.
- Tailored Solutions: Every study is different, and we customize our survival analysis methods to match your trial’s specific goals and endpoints.
Why PHARMA-STATS?
- Precision: We dig into the data with top-tier accuracy, helping you get the insights you need to make informed decisions.
- Advanced Tools: We use cutting-edge software and statistical models to handle even the most complex survival datasets.
- Ethics & Efficiency: Patient outcomes are at the center of everything we do, ensuring your trial respects both ethical standards and delivers actionable insights.
At PHARMA-STATS, we turn your time-to-event data into clear, impactful insights, ensuring every step of your clinical trial is driven by accuracy, efficiency, and ethical care. Let’s make your data work for you.
7. Specialized Oncology Expertise
Precision Where It Matters Most
At PHARMA-STATS, we’re more than just statisticians—we’re your go-to experts for navigating the complexities of oncology clinical trials. From early-stage trials to late-phase developments, our services are designed to meet the highest scientific and regulatory standards, ensuring your study is positioned for success from day one.
Our Oncology Experience Includes (but is not limited to):
- Selective Internal Radiation Therapy Comparisons: Analyzing treatment outcomes with precision.
- ALBI Score Validation: Helping assess liver function in hepatocellular carcinoma.
- Development of Scoring Algorithms: Tailored tools for better data insights in oncology.
- Cancer-Specific Health Utility Instruments: Capturing patient-reported outcomes that matter.
- Meta-Data Analysis for Publication: Turning raw data into peer-reviewed success.
- Comprehensive Project Support: From study design to final submission, we’ve got you covered.
Why PHARMA-STATS for Oncology Trials?
- Tailored Expertise: Whether it’s immunotherapy or precision medicine, we bring deep knowledge to optimize your trial for maximum impact.
- Regulatory Mastery: Our experience with global regulations ensures your data meets the rigorous standards of regulatory authorities.
- Innovative Statistical Methods: From Kaplan-Meier survival curves to Cox models, we use cutting-edge techniques to ensure your trial generates meaningful insights.
With PHARMA-STATS by your side, you’re not just running a trial—you’re collaborating with a team that understands the intricate nature of oncology research and knows how to turn your data into real-world, actionable outcomes.
8. Pharmacokinetic and Bioequivalence Studies
Streamlined for Success!
At PHARMA-STATS, we’ve perfected the art of designing and analyzing Pharmacokinetic (PK) and Bioequivalence (BE) studies. These are critical for proving the safety, efficacy, and equivalence of drugs, especially in the development of generics. Our cutting-edge statistical methods ensure you meet regulatory requirements with speed and precision, so your product gets to market faster.
Regulatory Support with No Surprises
We align every aspect of our PK and BE studies with global regulatory standards, ensuring your submissions are seamless and bulletproof. From study design to reporting, we make sure your data checks all the right boxes.
Why PHARMA-STATS?
- Tailored Study Designs: Every drug and every study is unique. We customize our designs to match your specific product, patient population, and therapeutic area.
- Proven Expertise: With our deep knowledge of PK/BE methodologies, we know exactly how to structure your study for success.
- Regulatory Mastery: We’ve got a track record of navigating the regulatory landscape like pros, ensuring your submissions are ready for approval, no matter the region.
Partnering with PHARMA-STATS means getting a team that knows how to guide you through the complex world of PK and BE studies—efficiently, accurately, and with regulatory-ready results from the start.
9. Therapeutic Area Proficiency
Precision for Every Field
At PHARMA-STATS, we deliver comprehensive biostatistical support tailored to a wide range of therapeutic areas. With years of experience and a skilled team, we ensure every study is designed and analyzed with laser-sharp precision, while staying aligned with global regulatory standards.
What We Cover:
Our expertise spans across therapeutic areas like: Oncology, Neurology, Infectious Diseases, Immunology, Dermatology, Respiratory, Endocrinology, Psychiatry, Urology, Paediatrics, Haematology, Cardiovascular, Diabetes, Nephrology, Gynaecology, Gastroenterology, Rheumatology, and Ophthalmology.
Why Choose PHARMA-STATS?
- Tailored Solutions: We don’t believe in one-size-fits-all. Every therapeutic area comes with its own challenges, and we customize our biostatistical solutions to meet those specific needs.
- Regulatory Ready: Our analyses are built with global compliance in mind, from regulatory standards, ensuring your submissions are seamless.
- Next-Level Stats: Using advanced methods like time-to-event analysis and longitudinal data models, we ensure your trial outcomes are accurate, reliable, and actionable.
With PHARMA-STATS, you’re partnering with a team that knows the ins and outs of every therapeutic area, ready to boost your clinical trials with efficiency and precision. Let’s elevate your research.
10. Extensive Clinical Trials Experience
Redefining Biostatistics
At PHARMA-STATS, we deliver specialized biostatistical services that are critical to clinical trial success. Our Unique Selling Proposition (USP) lies in the way we approach clinical trial analysis—from study design to sample size calculation and adaptive trial designs, ensuring that every study is compliant, efficient, and regulatory-ready.Â
With us, it’s not just about meeting standards; it’s about exceeding expectations.
What We Offer:
- Tailored Hypotheses & Endpoints: We work with you to define the right questions and endpoints to set your trial up for success from the very beginning.
- Smart Sample Size Calculation: Balancing power and feasibility, we ensure your study has the perfect sample size, adapting with mid-trial recalculations if necessary.
- Statistical Analysis Plans: From protocol development to final reporting, we use advanced tools like R to deliver transparent, detailed, and reliable analyses.
- Adaptive Trial Designs: Our flexible designs allow for real-time adjustments based on interim data, ensuring efficient timelines and better outcomes.
- Real-World Evidence (RWE): By integrating RWE, we provide a broader picture of how treatments work in real-world patient populations.
- Statistical Programming & Reporting: Our expert team specializes with R and many other programming languages, ensuring regulatory-ready reports that are both compliant and easily understandable by stakeholders.
- Â
Why PHARMA-STATS?
We minimize risk using validated methods, ensure regulatory compliance, reduce costs, and speed up timelines. Our biostatisticians support you through the entire process—from protocol development to regulatory acceptance. With innovation at our core and a proven track record, PHARMA-STATS is your trusted partner for efficient and successful drug development.
Let’s take your trials to the next level.